跳至主要内容
临床试验/NCT03504150
NCT03504150Unknown不适用

Comparative Effectiveness of Two Self-guided Web-based Interventions for Youth and Young Adults With Migraine

IWK Health Centre1 个研究点 分布在 1 个国家目标入组 424 人开始时间: 2018年5月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
424
试验地点
1
主要终点
Clinically significant improvement (50% reduction or greater) in number of headache days in a 4-week period from baseline to 4-months post-randomization

研究概览

简要总结

This randomized controlled trial will compare the effectiveness of two online self-guided programs for youth and young adults with migraine against usual care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
14 Years 至 40 Years(Child, Adult)
性别
All
接受健康志愿者
是

入选标准

  • •aged 14-40 years
  • •fluent in the English language (i.e., speaking, reading and writing);
  • •for 14-17 year olds: suffer from headaches for a minimum of three months
  • •for 18-40 year olds: suffer from headaches for a minimum of one year
  • •suffer from migraine headaches as indicated with a score of 2 and above on the ID Migraine
  • •have a Smartphone as PRISM has been designed to be accessed from a Smartphone and SPHERE encompasses the myWHI diary which has also been designed to be used from a Smartphone
  • •use the Smartphone for activities other than texting and calling (e.g., email, Facebook) as the programs are designed for migraineurs who are familiar with using Smartphones and use them in their daily life
  • •have daily Internet access from their Smartphone, because running the programs require an Internet connection
  • •minimum of four headache days during 4 weeks that they are asked to use an electronic headache diary

排除标准

  • •health care professional has not ruled out any underlying medical condition related to their headaches (e.g., head trauma, meningitis)
  • •are pregnant, planning to get pregnant (in the next 4 to 6 months), or breastfeeding, as hormonal changes are known to exert potent influences on migraine headaches
  • •have an impairment which compromises their ability to give informed consent
  • •having been diagnosed with psychosis and/or schizophrenia, because a past or current diagnosis may likely interfere with the participants ability to fully participate in the study
  • •have participated in our recent three-armed pilot RCT (i.e., any participant who consented and was randomized)
  • •they complete less than 50% of daily entries (i.e., less than 14 daily entries) in an electronic headache dairy when they asked to use it for 4 weeks
  • •More than 15 headache days during the 4 weeks that they are asked to use an electronic headache diary

研究组 & 干预措施

SPHERE

Experimental

It is an online self-guided comprehensive cognitive-behavioural therapy program that offers a headache diary, learning modules that teach a variety of cognitive and behavioural skills to cope better with their headaches, and a discussion forum where users may interact.

干预措施: SPHERE (Behavioral)

PRISM

Experimental

It is an online self-guided brief cognitive-behavioural therapy program that offers a headache diary and helps users discover their headache triggers and non-triggers. Then the program provides the users with a few personalized recommendations to help them to cope with their triggers.

干预措施: PRISM (Behavioral)

Usual care

No Intervention

结局指标

主要结局

Clinically significant improvement (50% reduction or greater) in number of headache days in a 4-week period from baseline to 4-months post-randomization

时间窗: At baseline and at 4-months post-randomization

An electronic headache diary will be asked to be used for 4 weeks. Each day participants will be asked to record whether or not they have experienced a headache.

次要结局

  • Level of acceptability to the treatments (i.e., PRISM and SPHERE)(At 4-months post-randomization)
  • Statistically significant improvement in peak headache severity in a 4-week period from baseline to 4-months post-randomization(At baseline and at 4-months post-randomization)
  • Statistically significant improvement in headache-related functional impairment from baseline to 4-months post-randomization(At baseline and at 4-months post-randomization)
  • Statistically significant improvement in depressive symptomatology from baseline to 4-months post-randomization.(At baseline and at 4-months post-randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anna Huguet

Principal investigator

IWK Health Centre

研究点 (1)

Loading locations...

相似试验